These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9475600)

  • 41. The MIller-Dieker syndrome.
    Jones KL; Gilbert EF; Kaveggia EG; Opitz JM
    Pediatrics; 1980 Aug; 66(2):277-81. PubMed ID: 7402813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple vertebral segmentation defects. Brief report of three patients and nosological considerations.
    Aslan Y; Erduran E; Mocan H; Yildiran A; Okten A; Gedik Y
    Genet Couns; 1997; 8(3):241-8. PubMed ID: 9327269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The significance of associated malformations of the central nervous system in myelomeningocele].
    Christensen B; Rand-Hendriksen S
    Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4232-4. PubMed ID: 9857808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging.
    Meadows J; Kraut M; Guarnieri M; Haroun RI; Carson BS
    J Neurosurg; 2000 Jun; 92(6):920-6. PubMed ID: 10839250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sibs with Ritscher-Schinzel (3C) syndrome and anal malformations.
    Orstavik KH; Bechensteen AG; Fugelseth D; Orderud W
    Am J Med Genet; 1998 Jan; 75(3):300-3. PubMed ID: 9475602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Posterior fossa neoplasm and PHACES syndrome: a case report.
    Wallen KE; Hadar EJ; Perry V; Bouldin TW; Loehr J; Blatt J
    J Pediatr Hematol Oncol; 2009 Mar; 31(3):203-5. PubMed ID: 19262249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malformation syndromes due to inborn errors of cholesterol synthesis.
    Porter FD
    J Clin Invest; 2002 Sep; 110(6):715-24. PubMed ID: 12235098
    [No Abstract]   [Full Text] [Related]  

  • 48. Ethylmalonic encephalopathy-report of two cases.
    Heberle LC; Al Tawari AA; Ramadan DG; Ibrahim JK
    Brain Dev; 2006 Jun; 28(5):329-31. PubMed ID: 16376514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spine and brain malformations in a patient obligate carrier of MTHFR with autism and mental retardation.
    Pavone V; Praticò AD; Parano E; Pavone P; Verrotti A; Falsaperla R
    Clin Neurol Neurosurg; 2012 Nov; 114(9):1280-2. PubMed ID: 22498705
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein.
    Tiranti V; D'Adamo P; Briem E; Ferrari G; Mineri R; Lamantea E; Mandel H; Balestri P; Garcia-Silva MT; Vollmer B; Rinaldo P; Hahn SH; Leonard J; Rahman S; Dionisi-Vici C; Garavaglia B; Gasparini P; Zeviani M
    Am J Hum Genet; 2004 Feb; 74(2):239-52. PubMed ID: 14732903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 46,XY/46,XX blood chimerism with severe central nervous system defect and multiple congenital malformations.
    Lieber C; Bordiuk J; Desposito F
    Am J Med Genet; 1986 Mar; 23(3):833-6. PubMed ID: 3953679
    [No Abstract]   [Full Text] [Related]  

  • 52. Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations.
    Acosta MT; Walsh KS; Kardel PG; Kutteruf RE; Bhatt RR; Bouton TC; Vezina LG; Packer RJ
    Pediatr Neurol; 2012 Apr; 46(4):231-4. PubMed ID: 22490768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive genetic-metabolic diseases of the central nervous system in children.
    Rapin I
    Pediatr Ann; 1976 May; 5(5):313-49. PubMed ID: 818604
    [No Abstract]   [Full Text] [Related]  

  • 54. [Approximation to the diagnosis of congenital metabolic disorders with neuroimaging].
    Campistol J
    Rev Neurol; 1999 Jan 1-15; 28(1):16-23. PubMed ID: 10101759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.
    Kılıç M; Dedeoğlu Ö; Göçmen R; Kesici S; Yüksel D
    Metab Brain Dis; 2017 Apr; 32(2):293-296. PubMed ID: 27830356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silent increase of urinary ethylmalonic acid is an indicator of nonspecific brain dysfunction.
    Zannolli R; Buoni S; Tassini M; De Nicola A; Betti G; De Felice C; Orsi A; Varetti MC; Ferrara F; Messina M; Giannini C; Mohn A; Chiarelli F; Liberati M; Strambi M; Funghini S; Vivi A; Wevers RA; Hayek J
    NMR Biomed; 2010 May; 23(4):353-8. PubMed ID: 20187168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffusion restriction in ethylmalonic encephalopathy - An imaging evidence of the pathophysiology of the disease.
    Bhat MD; Prasad C; Tiwari S; Chandra SR; Christopher R
    Brain Dev; 2016 Sep; 38(8):768-71. PubMed ID: 26992475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Syndrome delineation. 2. Inborn errors of metabolism, deformities, and variant familial developmental patterns.
    Herrmann J; Opitz JM
    Postgrad Med; 1979 Feb; 65(2):231-3, 236-7. PubMed ID: 419018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute Strokelike Presentation and Long-term Evolution of Diffusion Restriction Pattern in Ethylmalonic Encephalopathy.
    Lim J; Shayota BJ; Lay E; Elsea SH; Bekheirnia MR; Tessier MEM; Kralik SF; Rice GM; Soler-Alfonso C; Scaglia F
    J Child Neurol; 2021 Sep; 36(10):841-852. PubMed ID: 33900143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurometabolic disorders and congenital malformations of the central nervous system.
    BoAli AY; Alfadhel M; Tabarki B
    Neurosciences (Riyadh); 2018 Apr; 23(2):97-103. PubMed ID: 29664449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.